CL3-06593-018-laysummary-2023.06.14_EN

Home » Evaluation of the clinical efficacy and safety of perindopril 5 mg / indapamide 1.25 mg / amlodipine 5 mg fixed combination in single-pill after 2 months of treatment versus free combination, perindopril 4 mg / indapamide 1.25 mg + amlodipine 5 mg given separately at the same time, with conditional titration based on blood pressure control in patients with essential hypertension uncontrolled after 1 month with perindopril 4 mg / indapamide 1.25 mg bi-therapy. A national, multicentre, randomised, double blind, 7 months study. » CL3-06593-018-laysummary-2023.06.14_EN

© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.

Accessibility